
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Epidemiology of multiple sclerosis: results from a large observational study in the UK”, J Neurol, vol. 262, pp. 2033-41, 2015.
, “Mortality of patients with multiple sclerosis: a cohort study in UK primary care”, J Neurol, vol. 261, pp. 1508-17, 2014.
, “Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components”, Lancet, vol. 354, pp. 302-3, 1999.
, “Frequency of liver disease in type 2 diabetic patients treated with oral antidiabetic agents”, Diabetes Care, vol. 22, pp. 2067-71, 1999.
, “The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam”, Pharmacotherapy, vol. 20, pp. 741-4, 2000.
, “Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide”, Arch Dermatol, vol. 136, pp. 1231-6, 2000.
, “The risk of cataract among users of inhaled steroids”, Epidemiology, vol. 12, pp. 229-34, 2001.
, “Validity of the general practice research database”, Pharmacotherapy, vol. 23, pp. 686-9, 2003.
, “Statins and newly diagnosed diabetes”, Br J Clin Pharmacol, vol. 58, pp. 303-9, 2004.
, “Glucocorticoid use, other associated factors, and the risk of tuberculosis”, Arthritis Rheum, vol. 55, pp. 19-26, 2006.
, “Diclofenac and acute myocardial infarction in patients with no major risk factors”, Br J Clin Pharmacol, vol. 64, pp. 662-7, 2007.
, “Antidepressant drug use and risk of venous thromboembolism”, Pharmacotherapy, vol. 28, pp. 144-50, 2008.
, “The risk of unintended pregnancies in users of the contraceptive patch compared to users of oral contraceptives in the UK General Practice Research Database”, Contraception, vol. 80, pp. 142-51, 2009.
, “The risk of adverse outcomes in association with use of testosterone products: a cohort study using the UK-based general practice research database”, Br J Clin Pharmacol, vol. 75, pp. 260-70, 2013.
, “A follow-up safety study of ciprofloxacin users”, Pharmacotherapy, vol. 13, pp. 461-4, 1993.
, “Antidepressants and convulsions”, J Clin Psychopharmacol, vol. 12, pp. 241-5, 1992.
, “Antidepressants and suicide”, Bmj, vol. 310, pp. 215-8, 1995.
, “Anticonvulsants and congenital malformations”, Pharmacotherapy, vol. 17, pp. 561-4, 1997.
, “Pregnancies and terminations after 1995 warning about third-generation oral contraceptives”, Lancet, vol. 351, pp. 1404-5, 1998.
, “A study of the relation of exposure to quinolones and suicidal behaviour”, Br J Clin Pharmacol, vol. 45, pp. 77-81, 1998.
, “Quality and completeness of diagnoses recorded in the new CPRD Aurum Database: evaluation of pulmonary embolism”, Pharmacoepidemiol Drug Saf, 2020.
,